Cara Therapeutics

- NASDAQ:CARA
Last Updated 2021-09-14
  • Cara Therapeutics is a biotechnology company focused on developing therapeutics to treat diseases associated with pain and inflammation.
  • Locations

    • Shelton CT
  • Total Funding (USD)

    56.1 million
  • Industries

    Real Estate, Mobile Apps, Software, Cyber Security
  • Security

    Type: ORD
    CUSIP: 140755109
    ISIN: US1407551092
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.